BIONOMICS LIMITED - Announcements

0.00%

1.0¢

Currently unlisted.

Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical... Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of novel, ion channel targeting drug candidates designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders. The Company operates in drug development segment in Australia. The Company is advancing its lead drug candidate, BNC210, which is an oral, proprietary, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD). The Company has two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer’s disease and other central nervous system conditions.More

ASX:PAR

This stock could have something close to a cure for osteoarthritis. Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.

Announcements

Filter Results

All Price Sensitive Only

BNO	BNC105 Phase II Mesothelioma Clinical Trial Starts	PRICE SENSITIVE	26/03/10	39.57KB	Share
BNO	Bionomics NOW Newsletter March 2010		16/03/10	1.04MB	Share
BNO	BNC210 Clinical Trial Results	PRICE SENSITIVE	02/03/10	49.35KB	Share
BNO	Half Yearly Report and Accounts	PRICE SENSITIVE	18/02/10	1.36MB	Share
BNO	Appendix 3B		09/02/10	160.15KB	Share
BNO	U.S. Investor Presentation		09/02/10	1.6MB	Share
BNO	Bionomics Limited Broadcast		04/02/10	31.64KB	Share
BNO	Positive New BNC210 Data	PRICE SENSITIVE	02/02/10	1011.93KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/10	16.95KB	Share
BNO	BNC105 US Renal Cancer Trial Initiated	PRICE SENSITIVE	27/01/10	40.07KB	Share
BNO	Appendix 3B		21/01/10	160.42KB	Share
BNO	Appendix 3B		06/01/10	160.47KB	Share
BNO	Appendix 3B		05/01/10	160.34KB	Share
BNO	Appendix 3B		22/12/09	160.64KB	Share
BNO	Open Briefing - BNC105 Phase II Trial for Mesothelioma	PRICE SENSITIVE	22/12/09	227.91KB	Share
BNO	Appendix 3B		21/12/09	157.87KB	Share
BNO	Appointment of CFO and Company Secretary		18/12/09	22.83KB	Share
BNO	BNO Now December 09 Newsletter		14/12/09	329.04KB	Share
BNO	BNO to Conduct Phase II Trial in Mesothelioma	PRICE SENSITIVE	09/12/09	36.98KB	Share
BNO	Appendix 3B		12/11/09	390.61KB	Share
BNO	Change of Director's Interest Notice - TT		10/11/09	108.63KB	Share
BNO	Final Director's Interest Notice - PJ		10/11/09	102.09KB	Share
BNO	Change of Director's Interest Notice - DR		10/11/09	106.96KB	Share
BNO	Change of Director's Interest Notice EdS		10/11/09	108.69KB	Share
BNO	Change of Director's Interest Notice - CF		10/11/09	110.49KB	Share
BNO	Change of Director's Interest Notice		10/11/09	108.66KB	Share
BNO	Appendix 3B		09/11/09	397.08KB	Share
BNO	Bionomics 2009 AGM Broadcast		06/11/09	31.96KB	Share
BNO	Results of Meeting		04/11/09	52.43KB	Share
BNO	BNO Chairman's Address - AGM 2009		04/11/09	28.22KB	Share
BNO	BNO - Chris Fullerton AGM Presentation		04/11/09	29.12KB	Share
BNO	Bionomics CEO 2009 AGM Presentation		04/11/09	279.3KB	Share
BNO	Change in substantial holding		03/11/09	71.24KB	Share
BNO	Appendix 3B		03/11/09	392.55KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/09	80.91KB	Share
BNO	First Stage of BNC210 Clinical Trial Successfully Completed	PRICE SENSITIVE	27/10/09	35.89KB	Share
BNO	Latest BNC210 Data To Be Presented In US	PRICE SENSITIVE	16/10/09	180.05KB	Share
BNO	Change of Director's Interest Notice		13/10/09	105.11KB	Share
BNO	Appendix 3B		12/10/09	174.21KB	Share
BNO	Results of Meeting		09/10/09	73.44KB	Share
BNO	Invitation to Shareholders to Tour Bionomics Facility		08/10/09	22.31KB	Share
BNO	SPP Closes Oversubscribed		08/10/09	23.69KB	Share
BNO	Notice of Annual General Meeting/Proxy Form		02/10/09	328.26KB	Share
BNO	Annual Report to shareholders 2009		30/09/09	1.18MB	Share
BNO	Boardroom Radio Broadcast - BNO Investor Update Sept09		18/09/09	30.81KB	Share
BNO	Notice under Section 708A(6) of the Corps Act		17/09/09	25.7KB	Share
BNO	2009 Share Purchase Plan - Addendum		17/09/09	1.35MB	Share
BNO	Ceasing to be a substantial holder		17/09/09	22.14KB	Share
BNO	CEO Open Briefing	PRICE SENSITIVE	17/09/09	59.64KB	Share
BNO	Change in substantial holding		16/09/09	64.45KB	Share
BNO	2009 Share Purchase Plan Offer		16/09/09	650.41KB	Share
BNO	Appendix 3B		14/09/09	73.69KB	Share
BNO	BNO Capital Raising Update.		11/09/09	22.49KB	Share
BNO	Notice of Extraordinary General Meeting/Proxy Form		10/09/09	926.06KB	Share
BNO	BNO Presentation - Investor Update 2009		08/09/09	1.32MB	Share
BNO	Reinstatement to Official Quotation	PRICE SENSITIVE	08/09/09	8.03KB	Share
BNO	$15 Million Capital Raising	PRICE SENSITIVE	08/09/09	34.63KB	Share
BNO	Suspension from Official Quotation	PRICE SENSITIVE	07/09/09	17.49KB	Share
BNO	START-UP PLACEMENT		03/09/09	22.6KB	Share
BNO	Trading Halt	PRICE SENSITIVE	03/09/09	20.63KB	Share
BNO	Preliminary Final Report - Appendix 4E	PRICE SENSITIVE	28/08/09	76.16KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/09	79.39KB	Share
BNO	BNO - July Newsletter 09		27/07/09	433.06KB	Share
BNO	Notification of Unlisted Expired Options		08/07/09	20.94KB	Share
BNO	Open Briefing - BNO CEO on Milestones Achieved	PRICE SENSITIVE	02/07/09	63.12KB	Share
BNO	BNO - US Clinical Trial of BNC105 in Renal Cell Cancer	PRICE SENSITIVE	02/07/09	28.28KB	Share
BNO	BNO Broadcast - Healthy Investment eConference Presentation		01/07/09	32.62KB	Share
BNO	BNC210 Phase I Clinical Trial Initiated	PRICE SENSITIVE	25/06/09	36.81KB	Share
BNO	Boardroom Radio Broadcast - BNC210 Approved to Enter Trial		04/06/09	32.13KB	Share
BNO	Open Briefing BNC105 Interim Data	PRICE SENSITIVE	29/05/09	59.92KB	Share
BNO	Initial Data from BNC105 Phase I Clinical Trial Presented	PRICE SENSITIVE	29/05/09	25.46KB	Share
BNO	BNO Anxiety Drug Candidate Approved to Enter Human Trial	PRICE SENSITIVE	21/05/09	25.85KB	Share
BNO	BNO - CEO Presentation May 2009		05/05/09	1.64MB	Share
BNO	Open Briefing - New Data on BNC105	PRICE SENSITIVE	22/04/09	58.2KB	Share
BNO	New BNC105 Data Presented at AACR Conference	PRICE SENSITIVE	22/04/09	66.31KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	15/04/09	80.41KB	Share
BNO	Bionomics April 2009 Newsletter		09/04/09	304.34KB	Share
BNO	BNO - Boardroom Radio Broadcast - Half Yearly Report		03/03/09	31.92KB	Share
BNO	Change in substantial holding		02/03/09	68.07KB	Share
BNO	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/09	2.71MB	Share
BNO	Change of Director's Interest Notice		25/02/09	131.04KB	Share
BNO	Change in substantial holding		25/02/09	55.48KB	Share
BNO	Becoming a substantial holder		10/02/09	41.24KB	Share
BNO	Key Institutional Investor Supports BNO Capital Raising	PRICE SENSITIVE	10/02/09	30.19KB	Share
BNO	Disclosure Document Section 708A		10/02/09	20.25KB	Share
BNO	Appendix 3B		10/02/09	56.6KB	Share
BNO	BNO - Open Briefing	PRICE SENSITIVE	05/02/09	51.61KB	Share
BNO	BNOOB Options Exercise		30/01/09	19.83KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/09	17.35KB	Share
BNO	BNOOB - Reminder Letter		19/01/09	664.76KB	Share
BNO	Investor Presentation January 2009		19/01/09	1.64MB	Share
BNO	Open Briefing - CEO on Update	PRICE SENSITIVE	15/01/09	62.41KB	Share
BNO	Bionomics January 2009 Newsletter		14/01/09	376.3KB	Share
BNO	Initial Director's Interest Notice		08/01/09	52.13KB	Share
BNO	Addition to Board		23/12/08	22.95KB	Share
BNO	BNOOB Options Reminder		22/12/08	51.1KB	Share
BNO	BNC210 Successfully Completes Safety Studies	PRICE SENSITIVE	17/12/08	24.55KB	Share
BNO	Bionomics - Options Underwriting	PRICE SENSITIVE	16/12/08	28.12KB	Share

BNOBNC105 Phase II Mesothelioma Clinical Trial Starts
26/03/10	PRICE SENSITIVE	39.57KB	Share
BNOBionomics NOW Newsletter March 2010
16/03/10		1.04MB	Share
BNOBNC210 Clinical Trial Results
02/03/10	PRICE SENSITIVE	49.35KB	Share
BNOHalf Yearly Report and Accounts
18/02/10	PRICE SENSITIVE	1.36MB	Share
BNOAppendix 3B
09/02/10		160.15KB	Share
BNOU.S. Investor Presentation
09/02/10		1.6MB	Share
BNOBionomics Limited Broadcast
04/02/10		31.64KB	Share
BNOPositive New BNC210 Data
02/02/10	PRICE SENSITIVE	1011.93KB	Share
BNOAppendix 4C - quarterly
28/01/10	PRICE SENSITIVE	16.95KB	Share
BNOBNC105 US Renal Cancer Trial Initiated
27/01/10	PRICE SENSITIVE	40.07KB	Share
BNOAppendix 3B
21/01/10		160.42KB	Share
BNOAppendix 3B
06/01/10		160.47KB	Share
BNOAppendix 3B
05/01/10		160.34KB	Share
BNOAppendix 3B
22/12/09		160.64KB	Share
BNOOpen Briefing - BNC105 Phase II Trial for Mesothelioma
22/12/09	PRICE SENSITIVE	227.91KB	Share
BNOAppendix 3B
21/12/09		157.87KB	Share
BNOAppointment of CFO and Company Secretary
18/12/09		22.83KB	Share
BNOBNO Now December 09 Newsletter
14/12/09		329.04KB	Share
BNOBNO to Conduct Phase II Trial in Mesothelioma
09/12/09	PRICE SENSITIVE	36.98KB	Share
BNOAppendix 3B
12/11/09		390.61KB	Share
BNOChange of Director's Interest Notice - TT
10/11/09		108.63KB	Share
BNOFinal Director's Interest Notice - PJ
10/11/09		102.09KB	Share
BNOChange of Director's Interest Notice - DR
10/11/09		106.96KB	Share
BNOChange of Director's Interest Notice EdS
10/11/09		108.69KB	Share
BNOChange of Director's Interest Notice - CF
10/11/09		110.49KB	Share
BNOChange of Director's Interest Notice
10/11/09		108.66KB	Share
BNOAppendix 3B
09/11/09		397.08KB	Share
BNOBionomics 2009 AGM Broadcast
06/11/09		31.96KB	Share
BNOResults of Meeting
04/11/09		52.43KB	Share
BNOBNO Chairman's Address - AGM 2009
04/11/09		28.22KB	Share
BNOBNO - Chris Fullerton AGM Presentation
04/11/09		29.12KB	Share
BNOBionomics CEO 2009 AGM Presentation
04/11/09		279.3KB	Share
BNOChange in substantial holding
03/11/09		71.24KB	Share
BNOAppendix 3B
03/11/09		392.55KB	Share
BNOAppendix 4C - quarterly
29/10/09	PRICE SENSITIVE	80.91KB	Share
BNOFirst Stage of BNC210 Clinical Trial Successfully Completed
27/10/09	PRICE SENSITIVE	35.89KB	Share
BNOLatest BNC210 Data To Be Presented In US
16/10/09	PRICE SENSITIVE	180.05KB	Share
BNOChange of Director's Interest Notice
13/10/09		105.11KB	Share
BNOAppendix 3B
12/10/09		174.21KB	Share
BNOResults of Meeting
09/10/09		73.44KB	Share
BNOInvitation to Shareholders to Tour Bionomics Facility
08/10/09		22.31KB	Share
BNOSPP Closes Oversubscribed
08/10/09		23.69KB	Share
BNONotice of Annual General Meeting/Proxy Form
02/10/09		328.26KB	Share
BNOAnnual Report to shareholders 2009
30/09/09		1.18MB	Share
BNOBoardroom Radio Broadcast - BNO Investor Update Sept09
18/09/09		30.81KB	Share
BNONotice under Section 708A(6) of the Corps Act
17/09/09		25.7KB	Share
BNO2009 Share Purchase Plan - Addendum
17/09/09		1.35MB	Share
BNOCeasing to be a substantial holder
17/09/09		22.14KB	Share
BNOCEO Open Briefing
17/09/09	PRICE SENSITIVE	59.64KB	Share
BNOChange in substantial holding
16/09/09		64.45KB	Share
BNO2009 Share Purchase Plan Offer
16/09/09		650.41KB	Share
BNOAppendix 3B
14/09/09		73.69KB	Share
BNOBNO Capital Raising Update.
11/09/09		22.49KB	Share
BNONotice of Extraordinary General Meeting/Proxy Form
10/09/09		926.06KB	Share
BNOBNO Presentation - Investor Update 2009
08/09/09		1.32MB	Share
BNOReinstatement to Official Quotation
08/09/09	PRICE SENSITIVE	8.03KB	Share
BNO$15 Million Capital Raising
08/09/09	PRICE SENSITIVE	34.63KB	Share
BNOSuspension from Official Quotation
07/09/09	PRICE SENSITIVE	17.49KB	Share
BNOSTART-UP PLACEMENT
03/09/09		22.6KB	Share
BNOTrading Halt
03/09/09	PRICE SENSITIVE	20.63KB	Share
BNOPreliminary Final Report - Appendix 4E
28/08/09	PRICE SENSITIVE	76.16KB	Share
BNOAppendix 4C - quarterly
29/07/09	PRICE SENSITIVE	79.39KB	Share
BNOBNO - July Newsletter 09
27/07/09		433.06KB	Share
BNONotification of Unlisted Expired Options
08/07/09		20.94KB	Share
BNOOpen Briefing - BNO CEO on Milestones Achieved
02/07/09	PRICE SENSITIVE	63.12KB	Share
BNOBNO - US Clinical Trial of BNC105 in Renal Cell Cancer
02/07/09	PRICE SENSITIVE	28.28KB	Share
BNOBNO Broadcast - Healthy Investment eConference Presentation
01/07/09		32.62KB	Share
BNOBNC210 Phase I Clinical Trial Initiated
25/06/09	PRICE SENSITIVE	36.81KB	Share
BNOBoardroom Radio Broadcast - BNC210 Approved to Enter Trial
04/06/09		32.13KB	Share
BNOOpen Briefing BNC105 Interim Data
29/05/09	PRICE SENSITIVE	59.92KB	Share
BNOInitial Data from BNC105 Phase I Clinical Trial Presented
29/05/09	PRICE SENSITIVE	25.46KB	Share
BNOBNO Anxiety Drug Candidate Approved to Enter Human Trial
21/05/09	PRICE SENSITIVE	25.85KB	Share
BNOBNO - CEO Presentation May 2009
05/05/09		1.64MB	Share
BNOOpen Briefing - New Data on BNC105
22/04/09	PRICE SENSITIVE	58.2KB	Share
BNONew BNC105 Data Presented at AACR Conference
22/04/09	PRICE SENSITIVE	66.31KB	Share
BNOAppendix 4C - quarterly
15/04/09	PRICE SENSITIVE	80.41KB	Share
BNOBionomics April 2009 Newsletter
09/04/09		304.34KB	Share
BNOBNO - Boardroom Radio Broadcast - Half Yearly Report
03/03/09		31.92KB	Share
BNOChange in substantial holding
02/03/09		68.07KB	Share
BNOHalf Yearly Report and Accounts
25/02/09	PRICE SENSITIVE	2.71MB	Share
BNOChange of Director's Interest Notice
25/02/09		131.04KB	Share
BNOChange in substantial holding
25/02/09		55.48KB	Share
BNOBecoming a substantial holder
10/02/09		41.24KB	Share
BNOKey Institutional Investor Supports BNO Capital Raising
10/02/09	PRICE SENSITIVE	30.19KB	Share
BNODisclosure Document Section 708A
10/02/09		20.25KB	Share
BNOAppendix 3B
10/02/09		56.6KB	Share
BNOBNO - Open Briefing
05/02/09	PRICE SENSITIVE	51.61KB	Share
BNOBNOOB Options Exercise
30/01/09		19.83KB	Share
BNOAppendix 4C - quarterly
30/01/09	PRICE SENSITIVE	17.35KB	Share
BNOBNOOB - Reminder Letter
19/01/09		664.76KB	Share
BNOInvestor Presentation January 2009
19/01/09		1.64MB	Share
BNOOpen Briefing - CEO on Update
15/01/09	PRICE SENSITIVE	62.41KB	Share
BNOBionomics January 2009 Newsletter
14/01/09		376.3KB	Share
BNOInitial Director's Interest Notice
08/01/09		52.13KB	Share
BNOAddition to Board
23/12/08		22.95KB	Share
BNOBNOOB Options Reminder
22/12/08		51.1KB	Share
BNOBNC210 Successfully Completes Safety Studies
17/12/08	PRICE SENSITIVE	24.55KB	Share
BNOBionomics - Options Underwriting
16/12/08	PRICE SENSITIVE	28.12KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

BIONOMICS LIMITED - Announcements

Announcements

Top Stories